INCREDB ID : 124
Home >> Investigator Page Previous      Next
Arun Kumar Trivedi, Ph.D.
Scientist C 
 
Central Drug Research Institute
DTDD Division
Lucknow - 226 001   
Uttar Pradesh   
 
E-mail: arun3vedi@cdri.res.in
 
URL: http://www.cdriindia.org/aruntrivedi.htm
 
Positions Held:
Position Affiliation Time Period
Scientist C Central Drug Research Institute, Lucknow, India Present
 
Area of Specialization:
Molecular Oncology
Research Summary:
Molecular biology of acute myeloid leukemia and role of C/EBPalpha in leukemogenesis
Molecular biology and pathogenesis of breast cancer: mechanism of action of anti-cancer drugs and compounds using mass spectrometry based proteomics approach
 
Publications:
1. Bararia, D., Trivedi, A. K., Zada, A. A., Greif, P. A., Mulaw, M. A., Christopeit, M., Hiddemann, W., Bohlander, S. K. and Behre, G.  Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPalpha. Leukemia 2008.  22, 800-807. [PubMed]
2. Trivedi, A. K., Pal, P., Behre, G. and Singh, S. M.  Multiple ways of C/EBPalpha inhibition in myeloid leukaemia. European Journal of Cancer. 2008.  44, 1516-1523. [PubMed]
3. Singh, S. M., Trivedi, A. K. and Behre, G.  C/EBPalpha S248A mutation reduces granulocytic differentiation in human leukemic K562 cells. Biochemical and Biophysical Research Communications. 2008.  369, 692-694. [PubMed]
4. Geletu, M., Balkhi, M. Y., Peer, Z., Christopeit, M., Pulikkan, J. A., Trivedi, A. K., Tenen, D. G. and Behre, G.  Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9. Blood. 2007.  110, 3301-3309. [PubMed]
5. Trivedi, A. K., Bararia, D., Christopeit, M., Peerzada, A. A., Singh, S. M., Kieser, A., Hiddemann, W., Behre, H. M. and Behre, G.  Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene. 2007.  26, 1789-1801. [PubMed]
6. Balkhi, M. Y., Trivedi, A. K., Geletu, M., Christopeit, M., Bohlander, S. K., Behre, H. M. and Behre, G.  Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications. Oncogene. 2006.  25, 7041-7058. [PubMed]
7. Zada, A. A., Pulikkan, J. A., Bararia, D., Geletu, M., Trivedi, A. K., Balkhi, M. Y., Hiddemann, W. D., Tenen, D. G., Behre, H. M. and Behre, G.  Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad link. Leukemia 2006.  20, 2137-2146. [PubMed]

 
 
Education 
::
M.Sc. Banaras Hindu University, Varanasi, Uttar Pradesh, India
::
Ph.D. Ludwig Maximilians University, Munich, Germany
  Last modified on : Mar 4, 2011
India Cancer Research Database has been developed by the Institute of Bioinformatics with funding from the Department of Biotechnology, Government of India.